Experimental evidence and biomarker studies (13, 53, 54) have indicated that instability in atherosclerotic plaque was linked to decreased levels of circulating IL-17, contributing to a higher risk of cardiovascular diseases. Here, IL17A is linked to cardiovascular disorder.